Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study
- PMID: 15895401
- DOI: 10.1002/hep.20734
Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study
Abstract
The prevalence of and the risk factors for fatty liver have not undergone a formal evaluation in a representative sample of the general population. We therefore performed a cross-sectional study in the town of Campogalliano (Modena, Italy), within the context of the Dionysos Project. Of 5,780 eligible persons aged 18 to 75 years, 3,345 (58%) agreed to participate in the study. Subjects with suspected liver disease (SLD), defined on the basis of elevated serum alanine aminotransferase (ALT) and gamma-glutamyl-transferase (GGT) activity, hepatitis B surface antigen (HBsAg), or hepatitis C virus (HCV)-RNA positivity, were matched with randomly selected subjects of the same age and sex without SLD. A total of 311 subjects with and 287 without SLD underwent a detailed clinical, laboratory, and anthropometrical evaluation. Fatty liver was diagnosed by ultrasonography, and alcohol intake was assessed by using a 7-day diary. Multinomial logistic regression was used to detect risk factors for normal liver versus nonalcoholic fatty liver disease (NAFLD) and for alcoholic fatty liver (AFLD) versus NAFLD. The prevalence of NAFLD was similar in subjects with and without SLD (25 vs. 20%, P = .203). At multivariable analysis, normal liver was more likely than NAFLD in older subjects and less likely in the presence of obesity, hyperglycemia, hyperinsulinemia, hypertriglyceridemia, and systolic hypertension; AFLD was more likely than NAFLD in older subjects, males, and in the presence of elevated GGT and hypertriglyceridemia, and less likely in the presence of obesity and hyperglycemia. In conclusion, NAFLD is highly prevalent in the general population, is not associated with SLD, but is associated with many features of the metabolic syndrome.
Similar articles
-
Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.J Gastroenterol Hepatol. 2009 Jul;24(7):1284-8. doi: 10.1111/j.1440-1746.2009.05831.x. Epub 2009 May 19. J Gastroenterol Hepatol. 2009. PMID: 19476560
-
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question.Nutr Metab Cardiovasc Dis. 2007 Nov;17(9):684-98. doi: 10.1016/j.numecd.2007.01.007. Epub 2007 Jun 7. Nutr Metab Cardiovasc Dis. 2007. PMID: 17560098 Review.
-
Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures.Liver Int. 2006 Sep;26(7):856-63. doi: 10.1111/j.1478-3231.2006.01311.x. Liver Int. 2006. PMID: 16911469
-
The epidemiology of nonalcoholic fatty liver disease in adults.J Clin Gastroenterol. 2006 Mar;40 Suppl 1:S5-10. doi: 10.1097/01.mcg.0000168638.84840.ff. J Clin Gastroenterol. 2006. PMID: 16540768 Review.
-
Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.Am J Gastroenterol. 2003 Sep;98(9):2064-71. doi: 10.1111/j.1572-0241.2003.07640.x. Am J Gastroenterol. 2003. PMID: 14499789
Cited by
-
Association between nonalcoholic fatty liver disease and erectile dysfunction among American Adults from the National Health and Nutrition Examination Survey: a cross-sectional study.Int J Impot Res. 2024 May 23. doi: 10.1038/s41443-024-00914-6. Online ahead of print. Int J Impot Res. 2024. PMID: 38783042
-
The New FibroScan-AST (FAST) Score: Enhancing Diabetes Mellitus Impact on Metabolic-Associated Fatty Liver Disease.GE Port J Gastroenterol. 2022 Oct 24;30(6):422-429. doi: 10.1159/000527027. eCollection 2023 Dec. GE Port J Gastroenterol. 2022. PMID: 38476150 Free PMC article.
-
Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective.Diabetes Metab J. 2024 May;48(3):327-339. doi: 10.4093/dmj.2023.0350. Epub 2024 Feb 2. Diabetes Metab J. 2024. PMID: 38310873 Free PMC article. Review.
-
Gender perspective on the association between liver enzyme markers and non-alcoholic fatty liver disease: insights from the general population.Front Endocrinol (Lausanne). 2023 Dec 6;14:1302322. doi: 10.3389/fendo.2023.1302322. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38125795 Free PMC article.
-
Prevalence of Non-alcoholic Fatty Liver Disease in Iran: A Systematic Review and Meta-analysis.J Clin Exp Hepatol. 2024 Jan-Feb;14(1):101209. doi: 10.1016/j.jceh.2023.06.009. Epub 2023 Jun 29. J Clin Exp Hepatol. 2024. PMID: 38076354 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous